Jennifer Gudeman
Chief Tech/Sci/R&D Officer at AVADEL PHARMACEUTICALS PLC
Profile
Jennifer Gudeman is currently the Vice President-Medical & Clinical Affairs at Avadel Pharmaceuticals Plc since 2020.
Prior to this, she worked as the Director-Medical Affairs at AMAG Pharma USA, Inc. and as the Vice President-Medical Affairs at AMAG Pharmaceuticals, Inc. Dr. Gudeman completed her undergraduate degree in 1999 and her doctorate degree in 2000 from St. Louis College of Pharmacy.
Jennifer Gudeman active positions
| Companies | Position | Start |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 07/12/2020 |
Former positions of Jennifer Gudeman
| Companies | Position | End |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Jennifer Gudeman
| St. Louis College of Pharmacy | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| Private companies | 2 |
|---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Gudeman
